Zhang Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,546
Closed -$219K 308
2024
Q4
$219K Sell
2,546
-57
-2% -$6.16K 0.01% 274
2024
Q3
$310K Buy
2,603
+66
+3% +$8.8K 0.02% 226
2024
Q2
$362K Buy
2,537
+57
+2% +$7.55K 0.03% 212
2024
Q1
$318K Buy
+2,480
New +$295K 0.02% 218

Other funds holding NVO

Zhang Financial's NVO Position: Q1 2025 in Review

Zhang Financial sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,546 shares — an estimated $219K sold.

Zhang Financial first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $362K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Zhang Financial reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Zhang Financial sold 2,546 Novo Nordisk shares in Q1 2025, an estimated $219K.
  • Zhang Financial first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • Zhang Financial's Novo Nordisk position peaked at $362K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Zhang Financial's 13F filing for Q1 2025, filed 15 Apr 2025.